White Paper

The New Pharma Playbook

How clinical AI is changing pharma's role across the patient journey

Clinical AI has left the pilot. Physician use of AI has nearly doubled since 2023, and attention is moving from administrative tools to decision support built into care. But patients are still falling through the gaps, and the fix often stalls because no one owns the next step.

In October 2026, Viz.ai and HLTH brought clinical, health system and life sciences leaders together in Philadelphia for the AI Vizionaries Summit. This report captures what they shared about where care breaks down and what it will take for clinical AI to close those gaps at scale.

Inside the report:

  • Where patients get lost: the four stages where care stalls, and why the leak point shifts across rare disease, oncology and chronic conditions
  • The missing link: why ownership, not technology, decides whether clinical AI scales
  • Five moves for pharma: a practical playbook for partnering with health systems and clinical AI companies on care pathways, evidence generation and implementation
  • What clinicians expect: what pharma and technology partners need to show to earn trust at the point of care

Featuring perspectives from: Cleveland Clinic, Thomas Jefferson University, Cooper University Health, Integrated Medical Professionals, Sanofi, Merck and Viz.ai.